Síndrome de boca ardiente: descripción clínica, planteamiento fisiopatológico y una nueva opción terapéutica

Fonfría, A. Cárcamo; Gómez-Vicente, Lidia; Pedraza, M.I.; Cuadrado, María‐Luz; Peral, Á.L. Guerrero; Porta‐Etessam, Jesús

doi:10.1016/j.nrl.2015.10.008

Cited by 10 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, it is of interest that there have been 12 cases reported of burning mouth syndrome (BMS) at least partially responsive to dopamine agonists. [1][2][3] Classic BMS is characterized by an intraoral burning sensation and pain without an associated medical or dental etiology, and is typically not affected by mouth movement. In contrast, of the 12 reported dopaminergic-responsive cases of BMS, 11 reported worsening pain in the evening, and 10 reported improvement with eating, talking, or other mouth movement.…”

Section: Practical Implicationsmentioning

confidence: 99%

Restless mouth syndrome

et al. 2017

View full text Add to dashboard Cite

60-year-old man was referred to our headache clinic for evaluation of atypical facial pain. He reported a 1-year history of oral discomfort that began 2 to 3 months after a fall with trauma to the posterior neck. He described an uncomfortable but nonpainful sensation of swelling and numbness at the roof of the mouth that gradually spread to the tongue, bilateral buccal surfaces, and eventually the whole mouth. This was particularly prominent when his mouth was in a relaxed open position and was associated with a strong urge to move his jaw. Movement of the jaw and tongue provided temporary relief. He chewed gum for hours at a time to alleviate the symptoms, although the relief was sometimes only partial or intermittent. Keeping the jaw completely closed or clenching the teeth also provided improvement in his symptoms. Thus, he used a headband, pillow, or hand to keep the jaw closed. His symptoms began midmorning and persisted throughout the day, but were worse in the evening. The symptoms did not interfere with sleep as long as he was able to keep his jaw closed with a pillow. He denied xerostomia or xerophthalmia. He had a history of basal cell carcinoma of the left cheek status post resection 2 to 3 years ago without residual numbness. He had no personal or family history of trigeminal neuralgia, headaches, neuropathy, or restless legs syndrome (RLS). He had no history of having been on neuroleptics, antiemetics, or other dopamine antagonists. Before seeing us, he tried abstaining from caffeine and spicy food, and tried cinnamon, increased hydration, and vitamin B 12 without benefit. Trials of gabapentin 200 to 300 mg 3 times a day and pregabalin 200 mg twice a day also had not provided improvement. Oxcarbazepine, at an unknown dose, was ineffective and associated with anxiety and nervousness. Physical examination, including general and neurologic examination, was normal. There was no dystonic posturing observed in the tongue at rest, during speaking, or with rapid alternating movements.

show abstract

Section: Practical Implicationsmentioning

confidence: 99%

Restless mouth syndrome

et al. 2017

View full text Add to dashboard Cite

show abstract

Treatment Modalities of Burning Mouth Disease

Waal

2021

Burning Mouth Disease

View full text Add to dashboard Cite

Efficacy of photobiomodulation in reducing pain and improving the quality of life in patients with idiopathic burning mouth syndrome. A systematic review and meta-analysis

et al. 2022

View full text Add to dashboard Cite

Burning mouth syndrome is a chronic condition, which is characterised by a burning sensation or pain in the mucosa of the oral cavity. Treatment options include antidepressants, antipsychotics, anticonvulsants, analgesics, hormone replacement therapies and more recently photobiomodulation. This study aims to perform a systematic review with meta-analysis in order to determine the effect of photobiomodulation on pain relief and the oral health-related quality of life associated with this condition. A bibliographical search of the Pubmed, Embase, Web of Science and Scopus databases was conducted. Only randomised clinical trials were included. Pain and quality of life were calculated as mean difference and pooled at different treatment points (baseline = T0 and final time point = Tf) and laser modality. From a total of 103 records, 7 articles were retrieved for inclusion. PBM group had a greater decrease in pain than control group at Tf with a mean difference = − 2.536 (IC 95% − 3.662 to − 1.410; I2 = 85.33%, p < 0.001). An improvement in oral health-related quality of life was observed in both groups, although this was more significant in the photobiomodulation group mean difference = − 5.148 (IC 95% − 8.576 to − 1.719; I2 = 84.91%, p = 0.003). For the red laser, a greater improvement than infrared was observed, in pain, mean difference = − 2.498 (IC 95% − 3.942 to − 1.053; I2 = 79.93%, p < 0.001), and in quality of life, mean difference = − 8.144 (IC 95% − 12.082 to − 4.206; I2 = 64.22%, p = 0.027). Photobiomodulation, in particular, red laser protocols, resulted in improvement in pain and in quality of life of burning mouth syndrome patients.

show abstract

Síndrome de boca ardiente: descripción clínica, planteamiento fisiopatológico y una nueva opción terapéutica

Abstract: Burning mouth syndrome is a condition of unknown aetiology that shares certain clinical patterns and treatment responses with restless leg syndrome. Dopamine agonists should be regarded as first line treatment for this entity.

Cited by 10 publications

References 17 publications

Restless mouth syndrome

Restless mouth syndrome

Treatment Modalities of Burning Mouth Disease

Efficacy of photobiomodulation in reducing pain and improving the quality of life in patients with idiopathic burning mouth syndrome. A systematic review and meta-analysis

Contact Info

Product

Resources

About